Table 1.
Sample | Reference | T2 Cho [ms] |
T2 H2O [ms] |
T1 Cho [ms] |
T1H2O [ms] |
Field Strength [T] |
tCho Concentration |
---|---|---|---|---|---|---|---|
Cancer Patients | Bolan 2003 | 399 | 60 | 870 | 4 | 1.38–10 mmol/kg | |
Baik 2006, 2008 | 269 ± 61 | 97 ± 10 | 1513 ± 156 | 746 ± 118 | 1.5 | 0.76–21.20 mmol/kg | |
Sijens 2010 | 305† | 97 | 1513 | 746 | 1.5 | 2.8 & 3.4 mM | |
Bakken 2001 | 340 | 1.5 | |||||
Healthy Controls | Rakow-Penner 2006 | 57.51 | 1136, 1266* | 1.5 | |||
Rakow-Penner 2006 | 54.36 | 1324, 1445* | 3 | ||||
Graham 1997Δ | 40 | 1301 | 1.5 | ||||
Sijens 2010 | 311 | 49◊ | 1240 | 1317 | 1.5 | 0.3 & 0.6 mM | |
Phantom | Baik 2006 | 485–664 | 1122–1282 | 2301–2415 | 2574–2619 | 1.5 |
Average value based on Baik 2006 and Bakken 2011.
Values measured using two techniques.
Values measured in ex vivo breast tissue.
Average value based on Graham 1997 and Penner 2006.